Log In
Print
BCIQ
Print
Print this Print this
 

Prednisporin (FOV1101)

  Manage Alerts
Collapse Summary General Information
Company Epirus Biopharmaceuticals Inc.
DescriptionTopical formulation of prednisolone and cyclosporine A
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat allergic conjunctivitis
Regulatory Designation

Partner

Sanofi


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today